In this model, novel connections are revealed between the disease-associated CD40 transcriptional regulators such as RPL26 and other RA risk genes such as CD86, STAT4, ICAM1 TRAF1, and between RPL26 and proinflammatory cytokines such as IL6 and IL1β (Figure 5). This evidence concerns the gene CD86 and rheumatoid arthritis.